We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Kaposi Sarcoma in Kidney Transplant Recipients

Bryan D. Myers, MB, MRCP; Elena Kessler, MD; Joseph Levi, MD; Albert Pick, MD; Joseph B. Rosenfeld, MD
Arch Intern Med. 1974;133(2):307-311. doi:10.1001/archinte.1974.00320140145017.
Text Size: A A A
Published online


A growing experience with tumors of lymphoreticular origin in patients immunosuppressed to prolong homograft survival has been reported by Penn et al.1,2 In their most recent report,3 these authors have collected data on 17 such tumors reported from various centers, including their own. The predominant lymphoreticular malignant tumor was reticulum cell sarcoma, which accounted for 12 of the 17 cases, with a seeming predilection for an intracerebral situation. Three cases of Kaposi sarcoma are included in this group, of which two are from our practice. The third case was of the visceral variety, and the case records have been recounted in detail by Siegal et al.4 This article describes in detail the natural history of our two Kaposi sarcoma patients following intensive immunosuppressive therapy after renal transplantation.

Patient Summaries 

Patient 1.  —A 36-year-old woman had been found to have proteinuria in 1955 during an investigation for


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.